Ariel Gilmore
Endocrinology, Diabetes & Metabolism · Scottsdale, AZNPI 1356067516
Payments from drug & device makers
Across 64 payments — averaging $22.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$291
- Lilly USA, LLC$282
- AbbVie$222
- Novo Nordisk$98
- Dexcom, Inc.$94
- Tandem Diabetes Care, Inc.$65
- plus $401 from 14 others
What the payments were for
- Food & beverage$1,453100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 8 | $291 |
| Lilly USA, LLC | 14 | $282 |
| AbbVie | 12 | $222 |
| Novo Nordisk | 5 | $98 |
| Dexcom, Inc. | 3 | $94 |
| Tandem Diabetes Care, Inc. | 1 | $65 |
| Cequr Corporation | 2 | $50 |
| Amgen | 3 | $46 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Boehringer Ingelheim | 2 | $39 |
| Antares Pharma, Inc. | 2 | $37 |
| Bayer | 2 | $36 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
| Amryt Pharma Holdings Ltd | 1 | $21 |
| Halozyme Inc | 1 | $20 |
| Verity Pharmaceuticals Inc. | 1 | $19 |
| Recordati_rare_diseases_inc. | 1 | $19 |
| AstraZeneca | 1 | $18 |
| Insulet Corporation | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
How this compares
$1,453 in reported general payments places this provider in the 35th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.
See all endocrinology, diabetes & metabolism providers in Arizona →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 77 | $97,752 |
| OzempicSemaglutide | 45 | $64,000 |
| JardianceEmpagliflozin | 24 | $34,365 |
| FarxigaDapagliflozin Propanediol | 17 | $23,521 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $19,884 |
| Tresiba Flextouch U-100Insulin Degludec | 19 | $17,647 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $15,569 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 13 | $3,646 |
| SynthroidLevothyroxine Sodium | 18 | $1,308 |
| Levothyroxine Sodium | 99 | $1,022 |
| Metformin Hcl ErMetformin Hcl | 32 | $343 |
| Fenofibrate | 11 | $330 |
| Metformin Hcl | 22 | $306 |
| UnithroidLevothyroxine Sodium | 37 | $208 |
| Methimazole | 16 | $207 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $282 | $97,75277 claims |
| Novo NordiskOzempic | $98 | $64,00045 claims |
| Boehringer IngelheimJardiance | $39 | $34,36524 claims |
| AstraZenecaFarxiga | $18 | $23,52117 claims |
| AbbVieSynthroid | $222 | $1,30818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.
Other endocrinology, diabetes & metabolism in Scottsdale
- Amir HarariScottsdale$361K
- Kristina BlohmScottsdale$220K
- Andrea FerencziScottsdale$137K
- Abdul Razzak AlamirScottsdale$34K
- Sreedevi ReddyScottsdale$28K
- Grace Zlaket MattaScottsdale$17K
- Heather SaranScottsdale$14K
- Chandana MishraScottsdale$11K
- Vincent LiouScottsdale$10K
- Kimberlee BrontsemaScottsdale$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.